Literature DB >> 16730245

Simultaneous determination of baicalin, rhein and berberine in rat plasma by column-switching high-performance liquid chromatography.

Li Yi1, Gao Jian-Ping, Xu Xu, Dai Lixin.   

Abstract

A simple HPLC method using column-switching and ultraviolet detection was developed for the simultaneous determination of baicalin (BA), rhein (RH) and berberine (BE) in rat plasma. Plasma samples were injected directly onto a Capcell Pak MF C(8) column (150 mm x 4.6 mm i.d.) to remove protein and to be pre-separated by an isocratic elution using 50 mmol/L phosphate sodium (pH 6.85)-acetonitrile (10:1, v/v). After the drug-containing fractions were transferred to a Kromasil C(18) column (150 mm x 4.6 mm i.d.) by a valve switching step, the valve position was switched back and the main separation was performed by an isocratic elution using triethylamine adjusted 20 mmol/L phosphoric acid (pH 6.78)-acetonitrile (4:1, v/v). The flow rate was always 1.0 mL/min. The calibration curve showed excellent linear relationship (r>or=0.9997) over the concentration range of 0.4-7.9 microg/mL for baicalin, 0.2-7.8 microg/mL for rhein and 0.4-7.7 microg/mL for berberine in rat plasma. The intra- and inter-day assay precisions (R.S.D.) of three analytes were in the range of 0.34-4.3% and the accuracies were between 98.0% and 102.4%. Their recoveries were all greater than 95%. The method was successfully applied to the multi-constituents plasma concentration-time curve study after oral administration of a traditional Chinese medicine prescription Xiexin-Tang in rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730245     DOI: 10.1016/j.jchromb.2006.04.015

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  1 in total

1.  Study on the interaction of β-cyclodextrin and berberine hydrochloride and its analytical application.

Authors:  Baoxiu Jia; Yuqin Li; Decai Wang; Rui Duan
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.